A Dose-Escalation Study for Identifying Safe Doses of Coffee Cherry Pulp Juice Concentrate in Healthy Subjects
Article Sidebar
Main Article Content
Abstract
Previously viewed as industrial waste in coffee manufacture, coffee cherry pulp now receives attention as a functional food with potential health benefits. However, the maximum safe dose of this novel ingredient for human consumption was unknown. This dose-escalation study aimed to evaluate the safety and tolerability of coffee cherry pulp juice concentrate in healthy subjects and identify the maximum tolerated dose (MTD). In the single ascending dose phase, six participants received a single dose daily in a stepwise escalation from 1 to 14 g of coffee cherry pulp juice concentrate (50 ̊Brix), within 14 days. In the multiple ascending dose phase, twelve subjects received a stepwise escalating dose from 1 to 14 g of coffee cherry pulp juice concentrate twice daily (2-28 g per day). Each dose has been repeated for two weeks. Safety and tolerability were assessed by subject diaries and clinical laboratory tests. The results show no adverse events occurred after single or repeated doses. The average blood biochemical values are all in the normal range throughout the study. The maximum tolerated dose of coffee cherry pulp juice concentrate in short term is 14 g twice daily, which equals 28 g per day (total solid of 14 g). Future studies for the long-term safety of coffee cherry pulp juice concentrate are warranted.
Article Details
References
Wintgens JN. Coffee: Growing, processing, sustainable production. A guidebook for growers, processors, traders and researchers. 2nd ed. Weinheim: Wiley-VCH Verlag, 2009, 983 p.
Esquivel P, Jimenez VM. Functional properties of coffee and coffee by-products. Food Res Int 2012; 46(2): 488-495.
Ghosh P, Venkatachalapathy N. Processing and drying of coffee–a review. Int J Eng Res Technol 2014; 3(12): 784-94.
Banerjee S, Meghashree H, Haldar S. Coffee cultivation, processing and aroma: A detailed review. Acta Sci Nutr Health 2019; 3: 14-18.
de Melo Pereira GV, de Carvalho Neto DP, Júnior AIM, et al. Chemical composition and health properties of coffee and coffee by-products. Adv. Food Nutr Res 2020; 91: 65-96.
Brito T, Pereira A, Pastore G, et al. Chemical composition and physicochemical characterization for cabbage and pineapple by-products flour valorization. LWT 2020; 124:109028.
Klingel T, Kremer JI, Gottstein V, et al. A review of coffee by-products including leaf, flower, cherry, husk, silver skin, and spent grounds as novel foods within the European Union. Foods 2020; 9(5): 665.
Murthy PS, Naidu MM. Sustainable management of coffee industry by-products and value addition-A review. Resour Conserv Recycl 2012; 66: 45-58.
Carmen MT, Lorena ZC, Alexander VA et al. Coffee pulp: An industrial by-product with uses in agriculture, nutrition and biotechnology. Rev Agric Sci 2020; 8: 323-42.
Ramirez-Coronel MA, Marnet N, Kolli VK, et al. Characterization and estimation of proanthocyanidins and other phenolics in coffee pulp (Coffea Arabica)) by thiolysis- high-performance liquid chromatography. J Agric Food Chem 2004; 52(5): 1344-9.
Rojas JU, Verreth J, Amato S, et al. E. Biological treatments affect the chemical composition of coffee pulp. Bioresour Technol 2003; 89(3): 267-74.
Ontawong A, Duangjai A, Muanprasat C, et al. Lipid-lowering effects of Coffea arabica pulp aqueous extract in Caco-2 cells and hypercholesterolemic rats. Phytomedicine 2019; 52:187-97.
Ontawong A, Boonphang O, Pasachan T, et al. Hepatoprotective effect of coffee pulp aqueous extract combined with simvastatin against hepatic steatosis in high-fat diet-induced obese rats. J Funct Foods 2019; 54: 568-77.
Ontawong A, Pasachan T, Trisuwan K, et al. Coffea arabica pulp aqueous extract attenuates oxidative stress and hepatic lipid accumulation in HepG2 cells. J Herb Med 2021; 29: 100465.
Blinová L, Sirotiak M, Bartošová A, et al. Utilization of waste from coffee production. Research Papers Faculty of Materials Science and Technology Slovak University of Technology 2017; 25: 91-100.
Rolz C, Menchú JF, de Arriola MdC, et al. Pressing of coffee pulp. Agricultural Wastes 1980; 2(3): 207-14.
European Union. Commission Implementing Regulation (EU) 2017/2469 of 20 December 2017 laying down administrative and scientific requirements for applications referred to in Article 10 of Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods. 20 December 2017. Available at https://eur-lex.europa.eu/legal-content/EN/ TXT/?uri=CELEX:32017R2469, accessed on October 2, 2022.
Ministry of Public Health, Thailand. Ministry of Public Health Notification No. 376 B.E. 2559 (2016) Re: Novel Food. Available at http://food.fda.moph.go.th/law/data/announ_moph/V.English/No.376_Re_Novel_food.pdf, accessed on October 2, 2022.
Heimbach J, Marone P, Hunter J, et al. Safety studies on products from whole coffee fruit. Food Chem Toxicol 2010; 48(8-9): 2517-25.
US Food and drug administration. GRAS Notices GRN No.868 Coffee fruit extract. Last Updated: 07/27/2020 Available at https://www. Cfsanappsexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=868&sort=GRN_No&order=DESC&startrow=1&type=basic&search=868, accessed on October 2, 2022.
Ostojic SM, Stojanovic MD, Djordjevic B, et al. The effects of a 4-week coffeeberry supplementation on antioxidant status, endurance, and anaerobic performance in college athletes. Res Sports Med 2008; 16(4): 281-94.
Millán J, Pintó X, Muñoz A, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag 2009; 5: 757.
Moré MI, Postrach E, Bothe G, et al. A Dose-Escalation Study Demonstrates the Safety and Tolerability of Cellobiose in Healthy Subjects. Nutrients 2019; 12(1): 64.
Le Tourneau C, Lee JJ, Siu LL. Dose escalation methods in phase I cancer clinical trials. J Natl Cancer Inst 2009; 101(10): 708-20.
Kurzrock R, Lin CC, Wu TC, et al. Moving beyond 3+3: the future of clinical trial design. Am Soc Clin Oncol Educ Book 2021; 41: e133-e44.
Ministry of Public Health, Thailand. Ministry of Public Health Notification No. 355 B.E. 2556 (2013) Regarding to the Food in a Hermetically Sealed Container. Available at http://food.fda.moph.go.th/law/data/announ_moph/V. English/P355_E.pdf, accessed on October 2, 2022.
Lu MC, Lee IT, Hong LZ, et al. Coffeeberry Activates the CaMKII/ CREB/ BDNF Pathway, Normalizes Autophagy and Apoptosis Signaling in Nonalcoholic Fatty Liver Rodent Model. Nutrients 2021; 13(10):3652.
Huxley R, Lewington S, Clarke R. Cholesterol, coronary heart disease, and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med 2002; 02(3): 315-324.
Jeong SM, Choi S, Kim K, et al. Effect of change in total cholesterol levels on cardiovascular disease among young adults. J Am Heart Assoc 2018; 7(12): e008819.
Navas-Carretero S, Martinez JA. Cause-effect relationships in nutritional intervention studies for health claims substantiation: guidance for trial design. Int J Food Sci Nutr 2015; 66(S1): S53-S61.
